Markets:

Overview

News

Currencies

International

Treasuries

Provention Bio, Inc. - Common Stock (NQ:PRVB)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Provention Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company? ↗

June 15, 2023

Company Moves Ahead With Drug Development

Via Benzinga

Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis ↗

April 19, 2023

Tiziana Life Sciences (NASDAQ: TLSA), a London-based biotechnology company, is developing a first-in-class drug, Foralumab. Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) at the...

Via Benzinga

Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise ↗

April 12, 2023

Research is being done into whether there might be treatments that tackle Multiple Sclerosis (MS) through immunosuppression and a reduction of patient neuroinflammation. Anti-CD3 monoclonal antibodies...

Via Benzinga

Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information ↗

April 11, 2023

Via Benzinga

Is Sanofi Stock a Buy Now? ↗

March 25, 2023

The pharma giant has outperformed the broader market over the past 12 months.

Via The Motley Fool

Provention Bio's Earnings Outlook ↗

March 15, 2023

Via Benzinga

4 Analysts Have This to Say About Provention Bio ↗

March 14, 2023

Via Benzinga

Provention Bio's $2.9B Acquisition - A Strategic Fit For Sanofi ↗

March 13, 2023

Via Benzinga

Top 5 Health Care Stocks That May Crash In March ↗

March 22, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review ↗

March 17, 2023

A market rally is underway, but bank stocks kept tumbling.

Via Investor's Business Daily

Why Provention Bio Stock Skyrocketed 256% This Week ↗

March 16, 2023

Provention Bio is currently a partner of Sanofi. It should soon become a part of the big French drugmaker.

Via The Motley Fool

Why Shares of MacroGenics Climbed Thursday ↗

March 16, 2023

The cancer-focused biotech delivered a strong earnings report.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023 ↗

March 15, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 ↗

March 14, 2023

Via Benzinga

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs ↗

March 14, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners ↗

March 13, 2023

On a volatile market day, companies are still looking for smart combinations.

Via The Motley Fool

Nasdaq Up 150 Points; Gold Rises Over 2% ↗

March 13, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 150 points on Monday. The Dow traded up 0.59% to 32,096.68 while the NASDAQ rose 1.35% to 11,288.8. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 13, 2023

Via Benzinga

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.

Via Benzinga

Dow Jumps 300 Points; Crude Oil Down 1% ↗

March 13, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 300 points on Monday. The Dow traded up 0.94% to 32,210.33 while the NASDAQ rose 1.52% to 11,307.74. The S&P 500,...

Via Benzinga

Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗

March 13, 2023

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

US Stocks Mostly Higher; Dow Rises 75 Points ↗

March 13, 2023

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 75 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 31,986.55 while the NASDAQ rose...

Via Benzinga

Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal ↗

March 13, 2023

Pfizer expects Seagen to add at least $10 billion to its topline in 2030.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 13, 2023

Via Benzinga

Why Is First Republic Bank (FRC) Stock Down 61% Today? ↗

March 13, 2023

First Republic Bank (FRC) stock is falling hard on Monday as bank stocks react to the recent drama surrounding SVB Financial (SIVB).

Via InvestorPlace

Why Provention Bio Stock Is Rocketing Past 52-Week Highs Today ↗

March 13, 2023

Provention Bio Inc (NASDAQ: PRVB) shares are rocketing higher Monday after Sanofi (NASDAQ: SNY) announced plans to acquire the biopharmaceutical company.

Via Benzinga

Why Is Science 37 (SNCE) Stock Up 9% Today? ↗

March 13, 2023

Science 37 (SNCE) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees.

Via InvestorPlace

Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of...

Via Benzinga

Why Is Provention Bio (PRVB) Stock Up 263% Today? ↗

March 13, 2023

Provention Bio (PRVB) stock is rocketing higher on Monday following news that Sanofi (SNY) is acquiring the company for $2.9 billion.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 13, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday!

Via InvestorPlace

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.